Canntab Therapeutics Signs Joint Venture Agreement with Queensland Bauxite Subsidiary

Canntab Therapeutics has recently entered into a joint venture agreement with VitaCann, a subsidiary of Medical Cannabis, which is owned by Queensland Bauxite (ASX:QBL) in Australia. The Finance News Network published a video segment regarding the news, highlighting that the companies are working towards having Canntab tablets approved for sale within the Australian market and for export to Asia.
This joint venture has positioned Canntab and its Australian partner favorably to expand production and manufacturing of the Medical Cannabis seed bank and products within the Australian market.
To watch the full video segment, click here.
Click here to connect with Canntab Therapeutics for investor information.